Sophie Papa, FRCP PhD

Advisor

Sophie Papa is an Advisor at Raven, Founder and Chief Medical Officer of NexCure, and a Clinical Reader (Associate Professor) in Immuno-Oncology at King’s College London. She serves on the boards of Orion Corporation and T‑knife Therapeutics and is an advisor to Enara Bio and Sastra Cell Therapy.

Dr. Papa is a medical oncologist with more than twenty years of experience in cancer immunotherapy. She previously worked as a melanoma oncologist at Guy’s and St Thomas’ NHS Foundation Trust (GSTFT) in London, where she served as a principal investigator on the early phase trials team. Her clinical research experience spans first-in-human through late-phase studies. As program lead for cell therapy at GSTFT, she brought together multidisciplinary teams across GMP manufacturing, biological safety, and clinical care to deliver complex cellular therapies.

Dr. Papa earned her doctorate in solid tumor CAR‑T cell therapy from King’s College London. She completed her pre-clinical medical training at St John’s College, University of Oxford, and her clinical medical training at Imperial College London. She has published extensively in oncology and cancer immunology, was awarded a Medical Research Council Clinician Scientist Fellowship, and is a Fellow of the Royal College of Physicians, London.